Literature DB >> 12392549

The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments.

Daniele Sblattero1, Fiorella Florian, Elisabetta Azzoni, Trevin Zyla, Min Park, Valentina Baldas, Tarcisio Not, Alessandro Ventura, Andrew Bradbury, Roberto Marzari.   

Abstract

Celiac disease is an intestinal malabsorption characterized by an intolerance to cereal proteins accompanied by immunological responses to dietary gliadins and an autoantigen located in the endomysium. The latter has been identified as the enzyme tissue transglutaminase which belongs to a family of enzymes that catalyze protein cross-linking reactions and is constitutively expressed in many tissues as well as being activated during apoptosis. In a recent paper, we described the selection and characterization of anti-transglutaminase Igs from phage antibody libraries created from intestinal lymphocytes from celiac disease patients. In this work, using transglutaminase gene fragments, we identify a region of tissue transglutaminase recognized by these antibodies as being conformational and located in the core domain of the enzyme. This is identical to the region recognized by anti-transglutaminase Igs found in the serum of celiac disease patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392549     DOI: 10.1046/j.1432-1033.2002.03215.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Characterizing monoclonal antibody epitopes by filtered gene fragment phage display.

Authors:  Roberto Di Niro; Fortunato Ferrara; Tarcisio Not; Andrew R M Bradbury; Fernando Chirdo; Roberto Marzari; Daniele Sblattero
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

Review 2.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

3.  Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding.

Authors:  Greg Byrne; Fergus Ryan; John Jackson; Con Feighery; Jacinta Kelly
Journal:  Gut       Date:  2006-08-25       Impact factor: 23.059

4.  A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.

Authors:  Zsófia Simon-Vecsei; Róbert Király; Péter Bagossi; Boglárka Tóth; Ingrid Dahlbom; Sergio Caja; Éva Csosz; Katri Lindfors; Daniele Sblattero; Éva Nemes; Markku Mäki; László Fésüs; Ilma R Korponay-Szabó
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-22       Impact factor: 11.205

5.  Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients.

Authors:  Ingrid Dahlbom; Martin Olsson; Nahal Kazemi Forooz; Anders G Sjöholm; Lennart Truedsson; Tony Hansson
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

6.  Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.

Authors:  Kevin C O'Connor; Heiner Appel; Lisa Bregoli; Matthew E Call; Ingrid Catz; Jennifer A Chan; Nicole H Moore; Kenneth G Warren; Susan J Wong; David A Hafler; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

7.  Anti transglutaminase antibodies cause ataxia in mice.

Authors:  Sabrina Boscolo; Andrea Lorenzon; Daniele Sblattero; Fiorella Florian; Marco Stebel; Roberto Marzari; Tarcisio Not; Daniel Aeschlimann; Alessandro Ventura; Marios Hadjivassiliou; Enrico Tongiorgi
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

8.  Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease.

Authors:  D Agardh; K Lynch; C Brundin; S-A Ivarsson; A Lernmark; C M Cilio
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 9.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

10.  Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases.

Authors:  F Ferrara; S Quaglia; I Caputo; C Esposito; M Lepretti; S Pastore; R Giorgi; S Martelossi; G Dal Molin; N Di Toro; A Ventura; T Not
Journal:  Clin Exp Immunol       Date:  2009-11-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.